New developments in pediatric psychopharmacology.
This is a report on recent developments in pediatric psychopharmacology: new drugs and new applications for established drugs. The drugs reviewed include imipramine, amitryptiline, lithium, piracetam, propranolol, tryptophan, clonidine, pyridoxine and fenfluramine. Putative indications include prepubertal depression, school phobia, anorexia nervosa, explosive-aggressive behavior, learning disabilities, attention deficit disorder (hyperactivity), Tourette's syndrome, autism, and the Lesch-Nyhan syndrome. Some of the information presented in this report must be regarded as "preliminary," and caution is advised in its interpretation and application.
D000293:Adolescent; D000328:Adult; D000374:Aggression / Q000187:drug effects; D000856:Anorexia Nervosa / Q000188:drug therapy; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000627:therapeutic use; D001321:Autistic Disorder / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy; D007859:Learning Disabilities / Q000188:drug therapy; D008094:Lithium / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy*; D010698:Phobic Disorders / Q000188:drug therapy; D010889:Piracetam / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D011736:Pyridoxine / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D011619:Psychotropic Drugs; D008094:Lithium; D011433:Propranolol; D011736:Pyridoxine; D010889:Piracetam